Welcome to our comprehensive guide on Immuno-Oncology. In this article, we delve into CAR-T Cell Therapy: Innovations and Success, exploring the latest advancements and essential information.
Chimeric Antigen Receptor (CAR) T-cell therapy is a revolutionary treatment where a patient's own T-cells (a type of immune cell) are collected, genetically altered in a lab to better recognize cancer cells, and then infused back into the patient.
Currently, it is highly successful and FDA-approved for certain types of blood cancers, including aggressive lymphomas, some forms of leukemia, and multiple myeloma, especially in patients who have not responded to other treatments.
Yes. The therapy can cause severe side effects, notably Cytokine Release Syndrome (CRS), an intense immune response, and neurological toxicities. These require expert management in specialized treatment centers.